Cargando…
2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
2-Phenoxyacetamide group has been identified as one of markers in the discovery and development of SARS-CoV-2 antiviral agent through its main protease (M(pro)) inhibition pathway. This study aims to study a series of 2-phenoxyacetamide derivatives using in silico method toward SARS-CoV-2 M(pro) as...
Autores principales: | Hariyono, Pandu, Dwiastuti, Rini, Yusuf, Muhammad, Salin, Nurul H., Hariono, Maywan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666106/ https://www.ncbi.nlm.nih.gov/pubmed/34926138 http://dx.doi.org/10.1016/j.rechem.2021.100263 |
Ejemplares similares
-
Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies
por: Hariono, Maywan, et al.
Publicado: (2021) -
An integrated virtual screening of compounds from Carica papaya leaves against multiple protein targets of SARS-Coronavirus-2
por: Hariyono, Pandu, et al.
Publicado: (2021) -
Bioguided Fractionation of Local Plants against Matrix Metalloproteinase9 and Its Cytotoxicity against Breast Cancer Cell Models: In Silico and In Vitro Study
por: Hariono, Maywan, et al.
Publicado: (2020) -
Computational study of nitro-benzylidene phenazine as dengue virus-2 NS2B-NS3 protease inhibitor
por: Salin, Nurul Hanim, et al.
Publicado: (2022) -
A study on catalytic and non-catalytic sites of H5N1 and H1N1 neuraminidase as the target for chalcone inhibitors
por: Hariyono, Pandu, et al.
Publicado: (2021)